Thomas E. Locke

2.5k citations
26 papers · 1.8k · 5 hit papers · h-index 12

Impact in

Papers in

    • Antimicrobial Resistance in Staphylococcus 5
    • SARS-CoV-2 and COVID-19 Research 3
    • Glioma Diagnosis and Treatment 2

Thomas E. Locke

24 papers receiving 1.7k citations

Thomas E. Locke's Hit Papers

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis 2022 · 230 citations
2300+1+3Years since publication100200300400

Peers

Thomas E. Locke
Comparison fields: 5 of 111
  • Infectious Diseases 996
  • Applied Microbiology and Biotechnology 51
  • Neurology 354
  • Internal Medicine 56
  • Obstetrics and Gynecology 86
Replace Claire Bartlett with:
Claire Bartlett Canada
Robert W. Lord United Kingdom
Aoife Gatenby United Kingdom
Heather Hughes United States
Mustafa A. Abbas United Kingdom
Hadia Farooq United Kingdom
Pauline Lambert United Kingdom
Rebecca Ashworth United Kingdom
Hugo Gale United Kingdom
Marie Anne Ledingham United Kingdom
Thomas E. Locke relative to Claire Bartlett Canada Claire Bartlett's profile →
Citations per field
00.5×2×3×
Claire Bartlett · 1×
Citations per year

Countries citing papers authored by Thomas E. Locke

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Locke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Locke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Locke more than expected).

Fields of papers citing papers by Thomas E. Locke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Locke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Locke. The network helps show where Thomas E. Locke may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas E. Locke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas E. Locke Line = papers co-authored together Thomas E. Locke links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021403
2
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021381
3
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
4
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022230
5
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021211
6 202383
7 202330
8 202028
9 202324
10 202423
11 202120
12 202117
13 201212
14 201311
15 20258
16 20227
17 20135
18 20255
19 20183
20
Recruitment of primary care physicians to care for patients with human immunodeficiency virus infection in a large northwestern county.
19932

About Thomas E. Locke

Thomas E. Locke is a scholar working on Infectious Diseases, Genetics, Surgery, Microbiology and Epidemiology, having authored 26 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Glioma Diagnosis and Treatment (2 papers), Biochemical and Structural Characterization (1 paper), Poxvirus research and outbreaks (1 paper), Actinomycetales infections and treatment (1 paper), Abdominal vascular conditions and treatments (1 paper) and Mycorrhizal Fungi and Plant Interactions (1 paper). The work is most often cited by research in Infectious Diseases (996 citations), Applied Microbiology and Biotechnology (51 citations), Neurology (354 citations), Internal Medicine (56 citations) and Obstetrics and Gynecology (86 citations). Thomas E. Locke has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Sarv Priya, Girish Bathla, Caitlin E. Ward, Thomas C. Darton, Neetu Soni, Amit Kumar Agarwal, Fábio Bagnoli, Simone Pecetta, Sarah Rowland‐Jones and Varun Monga. Their work appears in journals such as The Lancet, Journal of Infection and Public Health, Microbial Genomics, International Journal of Antimicrobial Agents and Clinical Neurology and Neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact